Imricor Medical Systems rises on US FDA clearance for two devices
02/07/2026 02:14
BUZZ-Imricor Medical Systems rises on US FDA clearance for two devices ** Shares of ASX-listed Imricor Medical Systems IMR.AX rise as much as 16.3% to A$2.1, their highest level since late April
** U.S.-headquartered medical equipment maker gets Food and Drug Administration nod for its NorthStar mapping system and Vision-MR diagnostic catheter for pediatric label expansion
** The approval would allow co to market the two products for use with patients of any age, including children and young adults
** Stock up over 30% YTD
(Reporting by Shruti Agarwal in Bengaluru)
Recent news on Imricor Medical Systems
See all newsBrief: Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module
Brief: Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module
Brief: Imricor Medical Systems Says Anticipated FDA Clearances Of Additional Capital Equipment Expected To Broaden Product Offering Available To U.S. Customers
Imricor Medical Systems hits 3-month high on securing first US hospital customer
Brief: Imricor Medical Systems, Receives FDA 510(K) Clearance For Northstar Pediatric Label Expansion